NOVA RECTAL SUP 50MG 50 MG
PENTOBARBITAL SODIUM : 50 MG · DIN 00606510 · SABEX INC
Health Canada status: CANCELLED POST MARKET
What is NOVA RECTAL SUP 50MG?
NOVA RECTAL SUP 50MG 50 MG contains PENTOBARBITAL SODIUM : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00606510, held by SABEX INC, supplied as SUPPOSITORY for RECTAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00606510 |
|---|---|
| Brand name | NOVA RECTAL SUP 50MG |
| Generic / active ingredient | PENTOBARBITAL SODIUM : 50 MG |
| Manufacturer | SABEX INC |
| Strength | 50 MG |
| Dosage form | SUPPOSITORY |
| Route of administration | RECTAL |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| ATC code | N05CA01 PENTOBARBITAL |
| AHFS class | 28:24.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2001 |
| Original market date | 1984-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05CA01 PENTOBARBITAL. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEMBUTAL SODIUM CAP 100MG | 100 MG | CAPSULE | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 00000086 |
| NEMBUTAL SODIUM INJ 50MG/ML | 50 MG | SOLUTION | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 00000213 |
| NOVA RECTAL SUP 25MG | 25 MG | SUPPOSITORY | SABEX INC | CANCELLED POST MARKET | DIN 00606502 |
| NOVO-PENTOBARB 100MG | 100 MG | CAPSULE | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00020990 |
| PENTOBARBITAL SODIUM CAP 50MG | 50 MG | CAPSULE | SANDS PHARM | CANCELLED POST MARKET | DIN 00233994 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.